Veracyte Inc.

Veracyte Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.42
Market Cap
$1.37 B
Shares Outstanding
47.97 M
Public Float
32.12 M

Profile

Address
6000 Shoreline Court
South San Francisco California 94080
United States
Employees -
Website http://www.veracyte.com
Updated 07/08/2019
Veracyte, Inc. engages in the research, development, and commercialization of diagnostic products. Its portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis.

Financials

View All

Bonnie H. Anderson
Chairman & Chief Executive Officer
Kevin K. Gordon
Independent Director